力合科創(002243.SZ):擬出資1000萬元設立北京力合
格隆匯6月10日丨力合科創(002243.SZ)公佈,公司於2021年6月10日召開第五屆董事會第十七次會議、第五屆監事會第十七次會議審議並通過了《關於公司在北京設立全資子公司的議案》,同意公司出資1000萬元設立全資子公司力合科創(北京)創新中心有限公司(暫定名,以工商登記機關核准為準,“北京力合”)。北京力合將發揮公司科技創新服務、科技成果轉化功能,深入瞭解北京地區科技前沿發展趨勢,挖掘、整合當地創新資源、產業資源,開展科技成果轉化、投資孵化服務、產業合作、載體運營等一系列工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.